Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects With Nonresectable or Metastatic IDH1 Mutant Cholangiocarcinoma

Name: Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects With Nonresectable or Metastatic IDH1 Mutant Cholangiocarcinoma
License: Public Domain

Servier Bio-Innovation LLC

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

idh1-mutant cholangiocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 148775
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.